ReviewBJUI compass2026
Mixed reality applications in percutaneous stone surgery: A systematic review and meta-analysis of stone-free rate and perioperative complications.
Review in BJUI compass, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The aim of this study is to evaluate the effect of mixed reality (MR)-assisted percutaneous nephrolithotomy (PCNL) on stone-free rate (SFR), perioperative complications and operative efficiency. Methods: A search of PubMed, Embase and Web of Science from inception to February 2026 followed PRISMA guidelines. Studies comparing MR-assisted versus standard fluoroscopic or ultrasound-guided PCNL were included. Risk of bias was assessed using RoB2 and ROBINS-I. Random-effects meta-analyses calculated standardized mean differences (SMD) or risk ratios (RR) with 95% confidence intervals (CI). Results: Nine studies ( Conclusions: MR-assisted PCNL is associated with an apparent increase in SFR while maintaining comparable operative parameters and complication rates compared with standard techniques. Heterogeneity in these technologies and their applications limits generalizability. Larger, adequately powered standardized trials are recommended to interrogate key outcome measures including SFR and complication rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.